Furthermore, HIGD2A knock-down inhibited the activation of the MAPK/ERK pathway and the expression of BCL2L1, which could promote liver cancer cell apoptosis and suppress cell proliferation (Fig. 9). Here, HIGD2A is linked to liver cancer.